Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 1811121 | DCC-2618 ( Ripretinib ) | 1442472-39-0 | >98% |  |
| Ripretinib, also known as DCC-2618, is a potent, orally active and selective KIT/PDGF | ||||
| 1811162 | PF-05231023 | 1037589-69-7 | >98% |  |
| PF-05231023 is a long-acting FGF21 mimetic. PF-05231023 decreases body weight and imp | ||||
| 5141902 | Avatrombopag maleate | 677007-74-8 | 96% |  |
| Avatrombopag maleate is an orally bioavailable, small molecule thrombopoietin recepto | ||||
| 1811211 | Anlotinib HCl ( AL-3818 ) | 1360460-82-7 | ≧98.0% |  |
| Anlotinib is a novel oral tyrosine kinase inhibitor (TKI) targeting c-kit, platelet-d | ||||
| 19132 | Cilofexor ( GS-9674 ) | 1418274-28-8 | ≧98.0% |  |
| Cilofexor (also known as GS-9674) is a nonsteroidal farnesoid X receptor (FXR) agonis | ||||
| 191122 | Tafenoquine ( WR 238605 ) | 106635-80-7 | ≧98.0% |  |
| Tafenoquine is being investigated as a potential treatment for malaria, as well as fo | ||||
| 191146 | AR-9281 | 913548-29-5 | >98% |  |
| AR-9281 is a soluble epoxide hydrolase (s-EH) inhibitor potentially for the treatment | ||||
| 19356 | AZ876 | 898800-26-5 | >98% |  |
| AZ876, also known as AZ-876, is a liver X receptor agonist. AZ876 protects against pa | ||||
| S510901 | Cenicriviroc Mesylate | 497223-28-6 | 98% Min. |  |
| Cenicriviroc (CVC) is an oral, once-daily, potent immunomodulator that blocks two che | ||||
| 512193 | ITI-214(phosphate) | 1642303-38-5 | 98% Min. |  |
| ITI-214 is a potent and selective phosphodiesterase 1 (PDE1) inhibitor. As the clinic | ||||
| 52001 | Selisistat ( EX-527 ) | 49843-98-3 | ≧98.0% |  |
| Selisistatwas the first identified potent and cell permeable SIRT1-specific inhibitor | ||||
| 6111901 | UNC2541 | 1612782-86-1 | 98% Min. |  |
| UNC2541 is a potent and MerTK-specific inhibitor and exhibits sub-micro molar inhibit | ||||